• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用胎儿医学基金会的算法来确定预测巴西人群先兆子痫的截断值。

Using the algorithm of the Fetal Medicine Foundation to determine the cutoff point for prediction of pre-eclampsia in a Brazilian population.

机构信息

Department of Women's, Child and Adolescent Health, Assis Chateaubriand Maternity School, Federal University of Ceará (UFC), Fortaleza, Brazil.

University of Fortaleza (UNIFOR), Fortaleza, Brazil.

出版信息

Minerva Obstet Gynecol. 2023 Dec;75(6):503-511. doi: 10.23736/S2724-606X.22.05061-8. Epub 2022 Jun 22.

DOI:10.23736/S2724-606X.22.05061-8
PMID:35758093
Abstract

BACKGROUND

To use the algorithm of the Fetal Medicine Foundation (FMF) to determine the cutoff point for prediction of preeclampsia (PE) in a Brazilian population.

METHODS

Randomized clinical trial with 274 nulliparous patients at gestational age between 11 and 13 weeks and 6 days. To calculate the risk of PE, the algorithm available at the website of the FMF (http://fetalmedicine.org/research/assess/preeclampsia/first-trimester) was used. Among the patients, 138 did not use preventive measures (100 mg/day aspirin [ASA]). Youden's criteria were used to calculate the cutoff point. To test the effectiveness of 100 mg/day ASA in preventing PE, the patients were divided into two groups - at risk above and below the cutoff point.

RESULTS

In the group comprising the 135 patients that did not take ASA, the median age was 22 years, the Body Mass Index (BMI) was 59.3 kg/m, the mean arterial pressure (MAP) was 73.3 mmHg, and the mean pulsatility index of uterine artery Doppler was 1.71. The median gestational age at delivery was 39.3 (38.1-40.3) weeks. The prevalence of PE was 11.1%. In our sample, the use of 100 mg/day ASA reduced total PE by 36.3% (prevalence of PE in the group above the cutoff point was 19% and 12.1% when ASA and placebo were used, respectively).

CONCLUSIONS

The cutoff point defined for prediction of PE was 1:155 with sensitivity of 80%, specificity of 57.5%, positive predictive value of 19.1%, and negative predictive value of 95%, which should help to select patients that will benefit from prophylactic ASA.

摘要

背景

使用胎儿医学基金会(FMF)的算法来确定预测巴西人群先兆子痫(PE)的截止值。

方法

这是一项随机临床试验,纳入了 274 名孕龄在 11 至 13 周零 6 天的初产妇。为了计算 PE 的风险,使用了 FMF 网站上提供的算法(http://fetalmedicine.org/research/assess/preeclampsia/first-trimester)。在这些患者中,有 138 名患者未使用预防措施(每日 100mg 阿司匹林[ASA])。使用约登指数计算截止值。为了检验每日 100mg ASA 预防 PE 的有效性,将患者分为两个组 - 截止值以上和以下的风险组。

结果

在未服用 ASA 的 135 名患者中,中位数年龄为 22 岁,体重指数(BMI)为 59.3kg/m2,平均动脉压(MAP)为 73.3mmHg,子宫动脉多普勒搏动指数的平均值为 1.71。中位分娩孕周为 39.3(38.1-40.3)周。PE 的患病率为 11.1%。在我们的样本中,每日 100mg ASA 的使用将总 PE 降低了 36.3%(截止值以上组的 PE 患病率分别为 19%和 12.1%,当使用 ASA 和安慰剂时)。

结论

预测 PE 的截止值定义为 1:155,其灵敏度为 80%,特异性为 57.5%,阳性预测值为 19.1%,阴性预测值为 95%,这有助于选择将从预防性 ASA 中获益的患者。

相似文献

1
Using the algorithm of the Fetal Medicine Foundation to determine the cutoff point for prediction of pre-eclampsia in a Brazilian population.使用胎儿医学基金会的算法来确定预测巴西人群先兆子痫的截断值。
Minerva Obstet Gynecol. 2023 Dec;75(6):503-511. doi: 10.23736/S2724-606X.22.05061-8. Epub 2022 Jun 22.
2
Validation of Fetal Medicine Foundation algorithm for prediction of pre-eclampsia in the first trimester in an unselected Brazilian population.胎儿医学基金会算法在未选择的巴西人群中孕早期预测子痫前期的验证
J Matern Fetal Neonatal Med. 2019 Jan;32(2):286-292. doi: 10.1080/14767058.2017.1378332. Epub 2017 Sep 19.
3
Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.前瞻性评估亚洲人群中早孕期预测早产子痫前期模型的筛查性能。
Am J Obstet Gynecol. 2019 Dec;221(6):650.e1-650.e16. doi: 10.1016/j.ajog.2019.09.041. Epub 2019 Oct 4.
4
ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.ASPRE 试验:尽管进行了阿司匹林预防,早产子痫前期发展的风险因素。
Ultrasound Obstet Gynecol. 2021 Oct;58(4):546-552. doi: 10.1002/uog.23668. Epub 2021 Sep 6.
5
Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population.在一个本土南亚人群中,胎儿医学基金会算法进行早孕期子痫前期筛查的表现。
BMC Pregnancy Childbirth. 2021 Dec 4;21(1):805. doi: 10.1186/s12884-021-04283-6.
6
First-trimester screening for pre-eclampsia and small for gestational age: A comparison of the gaussian and Fetal Medicine Foundation algorithms.早孕期子痫前期和胎儿生长受限筛查:高斯算法和胎儿医学基金会算法的比较。
Int J Gynaecol Obstet. 2023 Jan;160(1):150-160. doi: 10.1002/ijgo.14306. Epub 2022 Jul 11.
7
ASPRE trial: performance of screening for preterm pre-eclampsia.ASPRE 试验:早产子痫前期筛查的表现。
Ultrasound Obstet Gynecol. 2017 Oct;50(4):492-495. doi: 10.1002/uog.18816. Epub 2017 Aug 24.
8
Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?常规早孕期子痫前期联合筛查:胎盘生长因子还是妊娠相关血浆蛋白 A?
Ultrasound Obstet Gynecol. 2021 Oct;58(4):540-545. doi: 10.1002/uog.23669. Epub 2021 Sep 13.
9
ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm.ASPRE 试验:根据 FMF 算法风险,符合 ACOG 和 NICE 标准的患者中早产子痫前期的发生率。
Ultrasound Obstet Gynecol. 2018 Jun;51(6):738-742. doi: 10.1002/uog.19019. Epub 2018 May 3.
10
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.预测和预防小于胎龄儿:来自 SPREE 和 ASPRE 的证据。
Ultrasound Obstet Gynecol. 2018 Jul;52(1):52-59. doi: 10.1002/uog.19077. Epub 2018 Jun 5.

引用本文的文献

1
First-trimester screening for fetal growth restriction and adverse maternal/perinatal outcomes.孕早期胎儿生长受限及不良母体/围产期结局筛查。
Radiol Bras. 2025 Sep 1;58:e20250031. doi: 10.1590/0100-3984.2025.0031. eCollection 2025 Jan-Dec.
2
First-trimester screening for preeclampsia between 11 and 13 + 6 weeks of gestation and adverse perinatal outcomes.孕11至13⁺⁶周子痫前期的孕早期筛查与不良围产结局
J Ultrasound. 2025 Jun 24. doi: 10.1007/s40477-025-01039-2.